ArticleiScience2025
Cell-based sialoglycan arrays for directly comparing influenza A virus receptor requirements for binding and infection.
Article in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Substitutions affecting the HA-NA-receptor balance preceded the emergence of the pandemic 2009 H1N1 virus.Proceedings of the National Academy of Sciences of the United States of America · 2026Article
- The receptor landscape of influenza A viruses.Journal of virology · 2026Review
- Deadbolt Drug Discovery: Locking the Door to Class 1 Viral Entry by Small Molecules.ACS infectious diseases · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Influenza A viruses multivalently engages sialoglycan attachment factors. Synthetic glycan arrays provide meticulous insight into primary binding specificity but do not capture dynamic post-binding virus-receptor interactions leading to cell entry. Establishing an HEK293 cell-based array of genetically dissected sialoglycan assemblies enabled screening of the complete interaction cascade from binding to infection, at physiologically relevant low virus doses. Screening forty years of H3N2 receptor binding evolution showed that besides N-glycans, deemed as principal receptors for primary attachment, specific O-glycans or glycosphingolipids independently supported all steps from primary binding to entry. For all three glycoconjugate classes, receptor preferences gradually evolved toward utilization of human-type α2-6-linked sialic acid receptors, followed by regaining use of avian-type α2-3-linked receptors after 1995. The screen identified a lack of quantitative correlation between binding and infection efficiency, suggesting specific receptor requirements beyond attachment. Virus-glycan interactions and other sialoglycan-dependent interactions with cells can be functionally analyzed using this system.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.